Abstract
The potentially deleterious effects of conventional right ventricular apical (RVA) pacing have been recognized increasingly, with particular emphasis on promoting cardiac dyssynchrony.1 Large-scale evaluations have demonstrated that RVA pacing may contribute to poor clinical outcomes. Increased RVA pacing predicted death or congestive heart failure (CHF) hospitalization in patients with implantable cardioverter-defibrillators with baseline depressed left ventricular (LV) function in the Dual Chamber and VVI Implantable Defibrillator trial2,3 and Multicenter Automatic Defibrillator Implantation Trial II4 as well as in patients with pacemakers examined in the Danish study5 and Mode Selection Trial.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
